Stay updated on Nivolumab Combo in Small Cell Lung Cancer Clinical Trial
Sign up to get notified when there's something new on the Nivolumab Combo in Small Cell Lung Cancer Clinical Trial page.

Latest updates to the Nivolumab Combo in Small Cell Lung Cancer Clinical Trial page
- Check5 days agoChange DetectedThe web page has been updated from version 2.16.2 to version 2.16.3.SummaryDifference0.1%
- Check12 days agoChange DetectedThe web page has been updated from version 2.16.1 to version 2.16.2.SummaryDifference0.1%
- Check19 days agoChange DetectedThe web page has been updated to announce the modernization of the ClinicalTrials.gov data ingest scheduled for June 2025, allowing API users to provide input. Additionally, the revision number has been updated from v2.16.0 to v2.16.1.SummaryDifference0.9%
- Check26 days agoChange DetectedThe web page has been updated to version 2.16.0, replacing the previous version 2.15.2.SummaryDifference0.2%
- Check48 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.1%
- Check63 days agoChange DetectedThe web page has been updated to include new collaborators for the study on lung cancer, specifically BeyondSpring Pharmaceuticals Inc., Bristol-Myers Squibb, and Rutgers Cancer Institute of New Jersey. Additionally, the revision number has been updated from v2.14.4 to v2.15.0.SummaryDifference41%
Stay in the know with updates to Nivolumab Combo in Small Cell Lung Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab Combo in Small Cell Lung Cancer Clinical Trial page.